TY - JOUR
T1 - Comparison of the long-term outcomes of mechanical and bioprosthetic aortic valves
T2 - A propensity score analysis
AU - Minakata, Kenji
AU - Tanaka, Shiro
AU - Tamura, Nobushige
AU - Yanagi, Shigeki
AU - Ohkawa, Yohei
AU - Okonogi, Shuichi
AU - Kaneko, Tatsuo
AU - Usui, Akihiko
AU - Abe, Tomonobu
AU - Shimamoto, Mitsuomi
AU - Takahara, Yoshiharu
AU - Yamanaka, Kazuo
AU - Yaku, Hitoshi
AU - Sakata, Ryuzo
N1 - Publisher Copyright:
© 2017, Japanese Circulation Society. All rights reserved.
PY - 2017
Y1 - 2017
N2 - Background: The aim of this study was to assess the long-term outcomes of aortic valve replacement (AVR) with either mechanical or bioprosthetic valves according to age at operation. Methods and Results: A total of 1,002 patients (527 mechanical valves and 475 bioprosthetic valves) undergoing first-time AVR were categorized according to age at operation: group Y, age <60 years; group M, age 60–69 years; and group O, age ≥70 years). Outcomes were compared on propensity score analysis (adjusted for 28 variables). Hazard ratio (HR) was calculated using the Cox regression model with adjustment for propensity score with bioprosthetic valve as a reference (HR=1). There were no significant differences in overall mortality between mechanical and bioprosthetic valves for all age groups. Valve-related mortality was significantly higher for mechanical valves in group O (HR, 2.53; P=0.02). Reoperation rate was significantly lower for mechanical valves in group Y (HR, 0.16; P<0.01) and group M (no events for mechanical valves). Although the rate of thromboembolic events was higher in mechanical valves in group Y (no events for tissue valves) and group M (HR, 9.05; P=0.03), there were no significant differences in bleeding events between all age groups. Conclusions: The type of prosthetic valve used in AVR does not significantly influence overall mortality.
AB - Background: The aim of this study was to assess the long-term outcomes of aortic valve replacement (AVR) with either mechanical or bioprosthetic valves according to age at operation. Methods and Results: A total of 1,002 patients (527 mechanical valves and 475 bioprosthetic valves) undergoing first-time AVR were categorized according to age at operation: group Y, age <60 years; group M, age 60–69 years; and group O, age ≥70 years). Outcomes were compared on propensity score analysis (adjusted for 28 variables). Hazard ratio (HR) was calculated using the Cox regression model with adjustment for propensity score with bioprosthetic valve as a reference (HR=1). There were no significant differences in overall mortality between mechanical and bioprosthetic valves for all age groups. Valve-related mortality was significantly higher for mechanical valves in group O (HR, 2.53; P=0.02). Reoperation rate was significantly lower for mechanical valves in group Y (HR, 0.16; P<0.01) and group M (no events for mechanical valves). Although the rate of thromboembolic events was higher in mechanical valves in group Y (no events for tissue valves) and group M (HR, 9.05; P=0.03), there were no significant differences in bleeding events between all age groups. Conclusions: The type of prosthetic valve used in AVR does not significantly influence overall mortality.
UR - http://www.scopus.com/inward/record.url?scp=85025821541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85025821541&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-17-0154
DO - 10.1253/circj.CJ-17-0154
M3 - Article
C2 - 28413185
AN - SCOPUS:85025821541
SN - 1346-9843
VL - 81
SP - 1198
EP - 1206
JO - Circulation Journal
JF - Circulation Journal
IS - 8
ER -